Chirality Regulates Stem Cell Fate and Promotes Corneal Epithelial Regeneration via Manipulating Notch Pathway
Source abstract
Abstract
Abstract The differentiation and stemness maintenance of stem cells are the core topics in cell biology and regenerative medicine, involving cell fate determination, developmental regulation and tissue regeneration. Chirality is an essential factor influencing multiple biological processes, including protein interactions, stem cell development and disease pathogenesis. However, its roles in regulating stem cells fate, especially limbal epithelial stem cells (LESCs), remain elusive. Herein, it is first discovered that right‐handed chiral hydrogel (DH) enhanced LESCs proliferation, migration, and differentiation into corneal epithelial cells, while left‐handed chiral hydrogel (LH) can partially preserve LESCs stemness. Further in vivo experiments demonstrated that 3D DH effectively accelerated corneal wound healing process, inhibited both inflammation and vascularization in a partial limbal stem cell deficiency model. Mechanistically, DH activates Notch signaling by increasing its stereo‐affinity to Notch1, facilitating Notch intracellular domain release and HES1 transcription, thereby directing LESCs fate. Collectively, this work highlights the novel role of chirality in LESCs fate determination and confirms DH as a drug‐free, effective approach for corneal epithelial regeneration, offering a new direction for regenerative medicine and tissue engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Corneal Surgery and Treatments · Ocular Surface and Contact Lens · Corneal surgery and disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Ophthalmology Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200011 China
State Key Laboratory of Eye Health Shanghai Jiao Tong University Shanghai 200011 China
State Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University Shanghai 200240 China
Funding
National Natural Science Foundation of China · Program of Shanghai Academic Research Leader · School of Medicine, Shanghai Jiao Tong University
References (58)
Show source-provided references
1. 10.1038/s41580-021-00386-210.1038/s41580-021-00386-2 ↗
2. 10.1002/adma.20200742910.1002/adma.202007429 ↗
3. 10.1038/cdd.2016.5310.1038/cdd.2016.53 ↗
4. 10.1007/s12015-023-10658-310.1007/s12015-023-10658-3 ↗
5. 10.1038/s41586-024-07478-x10.1038/s41586-024-07478-x ↗
6. 10.1002/advs.20230897510.1002/advs.202308975 ↗
7. 10.1056/NEJMra230443110.1056/NEJMra2304431 ↗
8. 10.1016/j.stem.2020.09.01410.1016/j.stem.2020.09.014 ↗
9. 10.1016/S0140-6736(24)01764-110.1016/S0140-6736(24)01764-1 ↗
10. 10.1016/j.stem.2019.03.02110.1016/j.stem.2019.03.021 ↗
11. 10.1038/s41593-020-00796-z10.1038/s41593-020-00796-z ↗
12. 10.1126/scirobotics.adp568210.1126/scirobotics.adp5682 ↗
13. 10.1016/j.stem.2018.05.01310.1016/j.stem.2018.05.013 ↗
14. 10.1016/j.preteyeres.2022.10109010.1016/j.preteyeres.2022.101090 ↗
15. 10.1186/s12951-023-01992-210.1186/s12951-023-01992-2 ↗
16. 10.1016/j.preteyeres.2021.10101110.1016/j.preteyeres.2021.101011 ↗
17. 10.1016/j.preteyeres.2015.07.00210.1016/j.preteyeres.2015.07.002 ↗
18. 10.1016/j.ophtha.2023.01.01610.1016/j.ophtha.2023.01.016 ↗
19. 10.1186/s12967-024-05603-y10.1186/s12967-024-05603-y ↗
20. 10.1016/j.ophtha.2024.02.01810.1016/j.ophtha.2024.02.018 ↗
21. 10.1016/j.jtos.2016.02.00610.1016/j.jtos.2016.02.006 ↗
22. 10.1093/stcltm/szab02810.1093/stcltm/szab028 ↗
23. 10.1016/j.jtos.2020.12.00810.1016/j.jtos.2020.12.008 ↗
24. 10.1167/iovs.61.5.710.1167/iovs.61.5.7 ↗
25. 10.1002/adfm.20241173510.1002/adfm.202411735 ↗
26. 10.1016/j.preteyeres.2024.10127510.1016/j.preteyeres.2024.101275 ↗
27. 10.1016/j.preteyeres.2021.10095610.1016/j.preteyeres.2021.100956 ↗
28. 10.1016/j.jtos.2016.04.00210.1016/j.jtos.2016.04.002 ↗
29. 10.1167/iovs.66.3.5210.1167/iovs.66.3.52 ↗
30. 10.1002/stem.74310.1002/stem.743 ↗
31. 10.3390/cells804034710.3390/cells8040347 ↗
32. 10.1038/s41418-023-01156-710.1038/s41418-023-01156-7 ↗
33. 10.1021/acs.accounts.0c0001210.1021/acs.accounts.0c00012 ↗
34. 10.1002/anie.20220253210.1002/anie.202202532 ↗
35. 10.1002/anie.20230707610.1002/anie.202307076 ↗
36. 10.1021/cr500671p10.1021/cr500671p ↗
37. 10.1038/nature1076910.1038/nature10769 ↗
38. 10.1002/adma.20220815710.1002/adma.202208157 ↗
39. 10.1002/adma.20230143510.1002/adma.202301435 ↗
40. 10.1002/adma.20190058210.1002/adma.201900582 ↗
41. 10.1039/D2CS00476C10.1039/D2CS00476C ↗
42. 10.1021/acsnano.3c1160110.1021/acsnano.3c11601 ↗
43. 10.1002/adma.20190564010.1002/adma.201905640 ↗
44. 10.1021/acsami.4c2102110.1021/acsami.4c21021 ↗
45. 10.1016/j.mtbio.2025.10146010.1016/j.mtbio.2025.101460 ↗
46. 10.1021/acsnano.4c1577010.1021/acsnano.4c15770 ↗
47. 10.1021/acsnano.4c1065310.1021/acsnano.4c10653 ↗
48. 10.1038/s41467-025-56137-w10.1038/s41467-025-56137-w ↗
49. 10.1002/advs.20230462710.1002/advs.202304627 ↗
50. 10.3390/pharmaceutics1612160410.3390/pharmaceutics16121604 ↗
51. 10.1016/j.carbpol.2021.11800610.1016/j.carbpol.2021.118006 ↗
52. 10.1016/j.compositesb.2024.11208710.1016/j.compositesb.2024.112087 ↗
53. 10.1016/j.ophtha.2004.09.02310.1016/j.ophtha.2004.09.023 ↗
54. 10.1016/j.nantod.2021.10130910.1016/j.nantod.2021.101309 ↗
55. 10.1186/s13287-020-02129-010.1186/s13287-020-02129-0 ↗
56. Sun N. · Bioact. Mater. · 2020 · 6 · 990
57. 10.1038/s41392-021-00824-910.1038/s41392-021-00824-9 ↗
58. 10.3390/cells909194510.3390/cells9091945 ↗